-
1
-
-
33749440087
-
Muscarinic acetylcholine receptors
-
Ishii M, Kurachi Y. Muscarinic acetylcholine receptors. Curr Pharm Des 2006;12:3573-3581.
-
(2006)
Curr Pharm des
, vol.12
, pp. 3573-3581
-
-
Ishii, M.1
Kurachi, Y.2
-
2
-
-
33847029091
-
Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system
-
Dani JA, Bertrand D. Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system. Annu Rev Pharmacol Toxicol 2007;47:699-729.
-
(2007)
Annu Rev Pharmacol Toxicol
, vol.47
, pp. 699-729
-
-
Dani, J.A.1
Bertrand, D.2
-
3
-
-
84926654297
-
Nicotinic acetylcholine receptors in autism spectrum disorders: Therapeutic implications
-
Springer: New York, NY
-
Deutsch SI, Schwartz BL, Urbano MR, Burket JA, Benson AD, Herndon AL. Nicotinic acetylcholine receptors in autism spectrum disorders: therapeutic implications. Comprehensive Guide to Autism. Springer: New York, NY, 2014:755-777.
-
Comprehensive Guide to Autism.
, vol.2014
, pp. 755-777
-
-
Deutsch, S.I.1
Schwartz, B.L.2
Urbano, M.R.3
Burket, J.A.4
Benson, A.D.5
Herndon, A.L.6
-
4
-
-
20744449198
-
Desensitization of nicotinic ACh receptors: Shaping cholinergic signaling
-
Giniatullin R, Nistri A, Yakel JL. Desensitization of nicotinic ACh receptors: shaping cholinergic signaling. Trends Neurosci 2005;28:371-378.
-
(2005)
Trends Neurosci
, vol.28
, pp. 371-378
-
-
Giniatullin, R.1
Nistri, A.2
Yakel, J.L.3
-
5
-
-
54049101939
-
Neuronal nicotinic acetylcholine receptors: From the genetic analysis to neurological diseases
-
Steinlein OK, Bertrand D. Neuronal nicotinic acetylcholine receptors: from the genetic analysis to neurological diseases. Biochem Pharmacol 2008;76:1175-1183.
-
(2008)
Biochem Pharmacol
, vol.76
, pp. 1175-1183
-
-
Steinlein, O.K.1
Bertrand, D.2
-
6
-
-
84883747611
-
Congenital myasthenic syndromes: An update
-
Hanta D, Nicole S, Eymard B. Congenital myasthenic syndromes: an update. Curr Opin Neurol 2013;26:561-568.
-
(2013)
Curr Opin Neurol
, vol.26
, pp. 561-568
-
-
Hanta, D.1
Nicole, S.2
Eymard, B.3
-
7
-
-
84866272011
-
Congenital myasthenic syndromes: Achievements and limitations of phenotype-guided gene-after-gene sequencing in diagnostic practice: A study of 680 patients
-
Abicht A, Dusl M, Gallenmller C, et al. Congenital myasthenic syndromes: achievements and limitations of phenotype-guided gene-after-gene sequencing in diagnostic practice: a study of 680 patients. Hum Mutat 2012;33:1474-1484.
-
(2012)
Hum Mutat
, vol.33
, pp. 1474-1484
-
-
Abicht, A.1
Dusl, M.2
Gallenmller, C.3
-
8
-
-
33947497536
-
The therapy of congenital myasthenic syndromes
-
Engel AG. The therapy of congenital myasthenic syndromes. Neurotherapeutics 2007;4:252-257.
-
(2007)
Neurotherapeutics
, vol.4
, pp. 252-257
-
-
Engel, A.G.1
-
9
-
-
84856015113
-
CHRNG genotype-phenotype correlations in the multiple pterygium syndromes
-
Vogt J, Morgan NV, Rehal P, et al. CHRNG genotype-phenotype correlations in the multiple pterygium syndromes. J Med Genet 2012;49:21-26.
-
(2012)
J Med Genet
, vol.49
, pp. 21-26
-
-
Vogt, J.1
Morgan, N.V.2
Rehal, P.3
-
10
-
-
84869837265
-
Nocturnal frontal lobe epilepsy and the acetylcholine receptor
-
Ferini-Strambi L, Sansoni V, Combi R. Nocturnal frontal lobe epilepsy and the acetylcholine receptor. Neurologist 2012;18:343-349.
-
(2012)
Neurologist
, vol.18
, pp. 343-349
-
-
Ferini-Strambi, L.1
Sansoni, V.2
Combi, R.3
-
11
-
-
84868196552
-
Missense mutations in the sodium-gated potassium channel gene KCNT1 cause severe autosomal dominant nocturnal frontal lobe epilepsy
-
Heron SE, Smith KR, Bahlo M, et al. Missense mutations in the sodium-gated potassium channel gene KCNT1 cause severe autosomal dominant nocturnal frontal lobe epilepsy. Nat Genet 2012;44:1188-1190.
-
(2012)
Nat Genet
, vol.44
, pp. 1188-1190
-
-
Heron, S.E.1
Smith, K.R.2
Bahlo, M.3
-
12
-
-
84872295116
-
Nicotinic acetylcholine receptors: From basic science to therapeutics
-
Hurst R, Rollema H, Bertrand D. Nicotinic acetylcholine receptors: from basic science to therapeutics. Pharmacol Ther 2013;137:22-54.
-
(2013)
Pharmacol Ther
, vol.137
, pp. 22-54
-
-
Hurst, R.1
Rollema, H.2
Bertrand, D.3
-
13
-
-
77954093814
-
Structures and molecular mechanisms for common 15q13.3 microduplications involving CHRNA7: Benign or pathological?
-
Szafranski P, Schaaf CP, Person RE, et al. Structures and molecular mechanisms for common 15q13.3 microduplications involving CHRNA7: benign or pathological? Hum Mutat 2010;31:840-850.
-
(2010)
Hum Mutat
, vol.31
, pp. 840-850
-
-
Szafranski, P.1
Schaaf, C.P.2
Person, R.E.3
-
14
-
-
80052026366
-
The chimeric gene CHRFAM7A, a partial duplication of the CHRNA7 gene, is a dominant negative regulator of a7 nAChR function
-
Araud T, Graw S, Berger R, et al. The chimeric gene CHRFAM7A, a partial duplication of the CHRNA7 gene, is a dominant negative regulator of a7 nAChR function. Biochem Pharmacol 2011;82:904-914.
-
(2011)
Biochem Pharmacol
, vol.82
, pp. 904-914
-
-
Araud, T.1
Graw, S.2
Berger, R.3
-
15
-
-
39749154724
-
A recurrent 15q13.3 microdeletion syndrome associated with mental retardation and seizures
-
Sharp AJ, Mefford HC, Li K, et al. A recurrent 15q13.3 microdeletion syndrome associated with mental retardation and seizures. Nat Genet 2008;40:322-328.
-
(2008)
Nat Genet
, vol.40
, pp. 322-328
-
-
Sharp, A.J.1
Mefford, H.C.2
Li, K.3
-
16
-
-
65949085347
-
Microdeletion/duplication at 15q13.2q13.3 among individuals with features of autism and other neuropsychiatric disorders
-
Miller DT, Shen Y, Weiss LA, et al. Microdeletion/duplication at 15q13.2q13.3 among individuals with features of autism and other neuropsychiatric disorders. J Med Genet 2009;46:242-248.
-
(2009)
J Med Genet
, vol.46
, pp. 242-248
-
-
Miller, D.T.1
Shen, Y.2
Weiss, L.A.3
-
17
-
-
67449114040
-
Microdeletion 15q13.3: A locus with incomplete penetrance for autism, mental retardation, and psychiatric disorders
-
Ben-Shachar S, Lanpher B, German JR, et al. Microdeletion 15q13.3: a locus with incomplete penetrance for autism, mental retardation, and psychiatric disorders. J Med Genet 2009;46:382-388.
-
(2009)
J Med Genet
, vol.46
, pp. 382-388
-
-
Ben-Shachar, S.1
Lanpher, B.2
German, J.R.3
-
18
-
-
68049129849
-
Further delineation of the 15q13 microdeletion and duplication syndromes: A clinical spectrum varying from nonpathogenic to a severe outcome
-
van Bon BW, Mefford HC, Menten B, et al. Further delineation of the 15q13 microdeletion and duplication syndromes: a clinical spectrum varying from nonpathogenic to a severe outcome. J Med Genet 2009;46:511-523.
-
(2009)
J Med Genet
, vol.46
, pp. 511-523
-
-
Van Bon, B.W.1
Mefford, H.C.2
Menten, B.3
-
19
-
-
49949085933
-
GROUP Large recurrent microdeletions associated with schizophrenia
-
Stefansson H, Rujescu D, Cichon S, et al.; GROUP. Large recurrent microdeletions associated with schizophrenia. Nature 2008;455:232-236.
-
(2008)
Nature
, vol.455
, pp. 232-236
-
-
Stefansson, H.1
Rujescu, D.2
Cichon, S.3
-
20
-
-
51649107017
-
Rare chromosomal deletions and duplications increase risk of schizophrenia
-
International Schizophrenia Consortium. Rare chromosomal deletions and duplications increase risk of schizophrenia. Nature 2008;455:237-241.
-
(2008)
Nature
, vol.455
, pp. 237-241
-
-
Schizophrenia Consortium, I.1
-
21
-
-
59149096726
-
15q13.3 microdeletions increase risk of idiopathic generalized epilepsy
-
Helbig I, Mefford HC, Sharp AJ, et al. 15q13.3 microdeletions increase risk of idiopathic generalized epilepsy. Nat Genet 2009;41:160-162.
-
(2009)
Nat Genet
, vol.41
, pp. 160-162
-
-
Helbig, I.1
Mefford, H.C.2
Sharp, A.J.3
-
22
-
-
70649089208
-
A small recurrent deletion within 15q13.3 is associated with a range of neurodevelopmental phenotypes
-
Shinawi M, Schaaf CP, Bhatt SS, et al. A small recurrent deletion within 15q13.3 is associated with a range of neurodevelopmental phenotypes. Nat Genet 2009;41:1269-1271.
-
(2009)
Nat Genet
, vol.41
, pp. 1269-1271
-
-
Shinawi, M.1
Schaaf, C.P.2
Bhatt, S.S.3
-
23
-
-
80052260252
-
A copy number variation morbidity map of developmental delay
-
Cooper GM, Coe BP, Girirajan S, et al. A copy number variation morbidity map of developmental delay. Nat Genet 2011;43:838-846.
-
(2011)
Nat Genet
, vol.43
, pp. 838-846
-
-
Cooper, G.M.1
Coe, B.P.2
Girirajan, S.3
-
24
-
-
78049242136
-
Homozygous loss of CHRNA7 on chromosome 15q13.3 causes severe encephalopathy with seizures and hypotonia
-
Endris V, Hackmann K, Neuhann TM, et al. Homozygous loss of CHRNA7 on chromosome 15q13.3 causes severe encephalopathy with seizures and hypotonia. Am J Med Genet A 2010;152A:2908-2911.
-
(2010)
Am J Med Genet A
, vol.152
, pp. 2908-2911
-
-
Endris, V.1
Hackmann, K.2
Neuhann, T.M.3
-
25
-
-
80054918557
-
A small homozygous microdeletion of 15q13.3 including the CHRNA7 gene in a girl with a spectrum of severe neurodevelopmental features
-
Liao J, DeWard SJ, Madan-Khetarpal S, Surti U, Hu J. A small homozygous microdeletion of 15q13.3 including the CHRNA7 gene in a girl with a spectrum of severe neurodevelopmental features. Am J Med Genet A 2011;155A:2795-2800.
-
(2011)
Am J Med Genet A
, vol.155
, pp. 2795-2800
-
-
Liao, J.1
Deward, S.J.2
Madan-Khetarpal, S.3
Surti, U.4
Hu, J.5
-
26
-
-
79960080944
-
Homozygous deletion of chromosome 15q13.3 including CHRNA7 causes severe mental retardation, seizures, muscular hypotonia, and the loss of KLF13 and TRPM1 potentially cause macrocytosis and congenital retinal dysfunction in siblings
-
Spielmann M, Reichelt G, Hertzberg C, et al. Homozygous deletion of chromosome 15q13.3 including CHRNA7 causes severe mental retardation, seizures, muscular hypotonia, and the loss of KLF13 and TRPM1 potentially cause macrocytosis and congenital retinal dysfunction in siblings. Eur J Med Genet 2011;54:e441-e445.
-
(2011)
Eur J Med Genet
, vol.54
, pp. e441-e445
-
-
Spielmann, M.1
Reichelt, G.2
Hertzberg, C.3
-
27
-
-
84867172514
-
Phenotypic heterogeneity of genomic disorders and rare copy-number variants
-
Girirajan S, Rosenfeld JA, Coe BP, et al. Phenotypic heterogeneity of genomic disorders and rare copy-number variants. N Engl J Med 2012;367:1321-1331.
-
(2012)
N Engl J Med
, vol.367
, pp. 1321-1331
-
-
Girirajan, S.1
Rosenfeld, J.A.2
Coe, B.P.3
-
28
-
-
84863116701
-
Genome-wide analysis of copy number variants in attention deficit hyperactivity disorder: The role of rare variants and duplications at 15q13.3
-
Williams NM, Franke B, Mick E, et al. Genome-wide analysis of copy number variants in attention deficit hyperactivity disorder: the role of rare variants and duplications at 15q13.3. Am J Psychiatry 2012;169:195-204.
-
(2012)
Am J Psychiatry
, vol.169
, pp. 195-204
-
-
Williams, N.M.1
Franke, B.2
Mick, E.3
-
29
-
-
84891165697
-
Genome-wide analysis of rare copy number variations reveals PARK2 as a candidate gene for attention-deficit/hyperactivity disorder
-
Jarick I, Volckmar AL, Putter C, et al. Genome-wide analysis of rare copy number variations reveals PARK2 as a candidate gene for attention-deficit/hyperactivity disorder. Mol Psychiatry 2014;19:115-121.
-
(2014)
Mol Psychiatry
, vol.19
, pp. 115-121
-
-
Jarick, I.1
Volckmar, A.L.2
Putter, C.3
-
30
-
-
84863116416
-
DeCODE Genetics; Psychiatric GWAS Consortium. Investigating the contribution of common genetic variants to the risk and pathogenesis of ADHD
-
Stergiakouli E, Hamshere M, Holmans P, et al.; deCODE Genetics; Psychiatric GWAS Consortium. Investigating the contribution of common genetic variants to the risk and pathogenesis of ADHD. Am J Psychiatry 2012;169:186-194.
-
(2012)
Am J Psychiatry
, vol.169
, pp. 186-194
-
-
Stergiakouli, E.1
Hamshere, M.2
Holmans, P.3
-
31
-
-
11844276603
-
Neuronal nicotinic receptors: From structure to pathology
-
Gotti C, Clementi F. Neuronal nicotinic receptors: from structure to pathology. Prog Neurobiol 2004;74:363-396.
-
(2004)
Prog Neurobiol
, vol.74
, pp. 363-396
-
-
Gotti, C.1
Clementi, F.2
-
32
-
-
0342596099
-
Nicotinic receptor function in schizophrenia
-
Leonard S, Adams C, Breese CR, et al. Nicotinic receptor function in schizophrenia. Schizophr Bull 1996;22:431-445.
-
(1996)
Schizophr Bull
, vol.22
, pp. 431-445
-
-
Leonard, S.1
Adams, C.2
Breese, C.R.3
-
33
-
-
0142259341
-
The genetics of sensory gating deficits in schizophrenia
-
Freedman R, Olincy A, Ross RG, et al. The genetics of sensory gating deficits in schizophrenia. Curr Psychiatry Rep 2003;5:155-161.
-
(2003)
Curr Psychiatry Rep
, vol.5
, pp. 155-161
-
-
Freedman, R.1
Olincy, A.2
Ross, R.G.3
-
34
-
-
0036897309
-
Association of promoter variants in the alpha7 nicotinic acetylcholine receptor subunit gene with an inhibitory deficit found in schizophrenia
-
Leonard S, Gault J, Hopkins J, et al. Association of promoter variants in the alpha7 nicotinic acetylcholine receptor subunit gene with an inhibitory deficit found in schizophrenia. Arch Gen Psychiatry 2002;59:1085-1096.
-
(2002)
Arch Gen Psychiatry
, vol.59
, pp. 1085-1096
-
-
Leonard, S.1
Gault, J.2
Hopkins, J.3
-
35
-
-
84887097223
-
A review of the pharmacology, efficacy and tolerability of recently approved and upcoming oral antipsychotics: An evidence-based medicine approach
-
Citrome L. A review of the pharmacology, efficacy and tolerability of recently approved and upcoming oral antipsychotics: an evidence-based medicine approach. CNS Drugs 2013;27:879-911.
-
(2013)
CNS Drugs
, vol.27
, pp. 879-911
-
-
Citrome, L.1
-
36
-
-
0020686674
-
Alzheimers disease: A disorder of cortical cholinergic innervation
-
Coyle JT, Price DL, DeLong MR. Alzheimers disease: a disorder of cortical cholinergic innervation. Science 1983;219:1184-1190.
-
(1983)
Science
, vol.219
, pp. 1184-1190
-
-
Coyle, J.T.1
Price, D.L.2
Delong, M.R.3
-
37
-
-
0035251750
-
Nicotinic receptor abnormalities in Alzheimers disease
-
Court J, Martin-Ruiz C, Piggott M, Spurden D, Griffiths M, Perry E. Nicotinic receptor abnormalities in Alzheimers disease. Biol Psychiatry 2001;49:175-184.
-
(2001)
Biol Psychiatry
, vol.49
, pp. 175-184
-
-
Court, J.1
Martin-Ruiz, C.2
Piggott, M.3
Spurden, D.4
Griffiths, M.5
Perry, E.6
-
38
-
-
0032971370
-
Expression of nicotinic acetylcholine receptor subunits in the cerebral cortex in Alzheimers disease: Histotopographical correlation with amyloid plaques and hyperphosphorylatedtau protein
-
Wevers A, Monteggia L, Nowacki S, et al. Expression of nicotinic acetylcholine receptor subunits in the cerebral cortex in Alzheimers disease: histotopographical correlation with amyloid plaques and hyperphosphorylatedtau protein. Eur J Neurosci 1999;11:2551-2565.
-
(1999)
Eur J Neurosci
, vol.11
, pp. 2551-2565
-
-
Wevers, A.1
Monteggia, L.2
Nowacki, S.3
-
39
-
-
4344698859
-
Smoking, nicotine and Parkinsons disease
-
Quik M. Smoking, nicotine and Parkinsons disease. Trends Neurosci 2004;27:561-568.
-
(2004)
Trends Neurosci
, vol.27
, pp. 561-568
-
-
Quik, M.1
-
40
-
-
10144229353
-
New mutations in acetylcholine receptor subunit genes reveal heterogeneity in the slow-channel congenital myasthenic syndrome
-
Engel AG, Ohno K, Milone M, et al. New mutations in acetylcholine receptor subunit genes reveal heterogeneity in the slow-channel congenital myasthenic syndrome. Hum Mol Genet 1996;5:1217-1227.
-
(1996)
Hum Mol Genet
, vol.5
, pp. 1217-1227
-
-
Engel, A.G.1
Ohno, K.2
Milone, M.3
-
41
-
-
0030987817
-
Mutations in different functional domains of the human muscle acetylcholine receptor alpha subunit in patients with the slow-channel congenital myasthenic syndrome
-
Croxen R, Newland C, Beeson D, et al. Mutations in different functional domains of the human muscle acetylcholine receptor alpha subunit in patients with the slow-channel congenital myasthenic syndrome. Hum Mol Genet 1997;6:767-774.
-
(1997)
Hum Mol Genet
, vol.6
, pp. 767-774
-
-
Croxen, R.1
Newland, C.2
Beeson, D.3
-
42
-
-
0029087136
-
Mutation of the acetylcholine receptor alpha subunit causes a slow-channel myasthenic syndrome by enhancing agonist binding affinity
-
Sine SM, Ohno K, Bouzat C, et al. Mutation of the acetylcholine receptor alpha subunit causes a slow-channel myasthenic syndrome by enhancing agonist binding affinity. Neuron 1995;15:229-239.
-
(1995)
Neuron
, vol.15
, pp. 229-239
-
-
Sine, S.M.1
Ohno, K.2
Bouzat, C.3
-
43
-
-
0030757151
-
Slow-channel myasthenic syndrome caused by enhanced activation, desensitization, and agonist binding affinity attributable to mutation in the M2 domain of the acetylcholine receptor alpha subunit
-
Milone M, Wang HL, Ohno K, et al. Slow-channel myasthenic syndrome caused by enhanced activation, desensitization, and agonist binding affinity attributable to mutation in the M2 domain of the acetylcholine receptor alpha subunit. J Neurosci 1997;17:5651-5665.
-
(1997)
J Neurosci
, vol.17
, pp. 5651-5665
-
-
Milone, M.1
Wang, H.L.2
Ohno, K.3
-
44
-
-
0033363317
-
Acetylcholine receptor M3 domain: Stereochemical and volume contributions to channel gating
-
Wang HL, Milone M, Ohno K, et al. Acetylcholine receptor M3 domain: stereochemical and volume contributions to channel gating. Nat Neurosci 1999;2:226-233.
-
(1999)
Nat Neurosci
, vol.2
, pp. 226-233
-
-
Wang, H.L.1
Milone, M.2
Ohno, K.3
-
45
-
-
0037329589
-
Mutation causing severe myasthenia reveals functional asymmetry of AChR signature cystine loops in agonist binding and gating
-
Shen XM, Ohno K, Tsujino A, et al. Mutation causing severe myasthenia reveals functional asymmetry of AChR signature cystine loops in agonist binding and gating. J Clin Invest 2003;111:497-505.
-
(2003)
J Clin Invest
, vol.111
, pp. 497-505
-
-
Shen, X.M.1
Ohno, K.2
Tsujino, A.3
-
46
-
-
57149106806
-
HnRNP H enhances skipping of a nonfunctional exon P3A in CHRNA1 and a mutation disrupting its binding causes congenital myasthenic syndrome
-
Masuda A, Shen XM, Ito M, Matsuura T, Engel AG, Ohno K. hnRNP H enhances skipping of a nonfunctional exon P3A in CHRNA1 and a mutation disrupting its binding causes congenital myasthenic syndrome. Hum Mol Genet 2008;17:4022-4035.
-
(2008)
Hum Mol Genet
, vol.17
, pp. 4022-4035
-
-
Masuda, A.1
Shen, X.M.2
Ito, M.3
Matsuura, T.4
Engel, A.G.5
Ohno, K.6
-
47
-
-
1842475995
-
Mutation in the AChR ion channel gate underlies a fast channel congenital myasthenic syndrome
-
Webster R, Brydson M, Croxen R, Newsom-Davis J, Vincent A, Beeson D. Mutation in the AChR ion channel gate underlies a fast channel congenital myasthenic syndrome. Neurology 2004;62:1090-1096.
-
(2004)
Neurology
, vol.62
, pp. 1090-1096
-
-
Webster, R.1
Brydson, M.2
Croxen, R.3
Newsom-Davis, J.4
Vincent, A.5
Beeson, D.6
-
48
-
-
40749093330
-
Acetylcholine receptor pathway mutations explain various fetal akinesia deformation sequence disorders
-
Michalk A, Stricker S, Becker J, et al. Acetylcholine receptor pathway mutations explain various fetal akinesia deformation sequence disorders. Am J Hum Genet 2008;82:464-476.
-
(2008)
Am J Hum Genet
, vol.82
, pp. 464-476
-
-
Michalk, A.1
Stricker, S.2
Becker, J.3
-
49
-
-
33746578967
-
Increased sensitivity of the neuronal nicotinic receptor alpha 2 subunit causes familial epilepsy with nocturnal wandering and ictal fear
-
Aridon P, Marini C, Di Resta C, et al. Increased sensitivity of the neuronal nicotinic receptor alpha 2 subunit causes familial epilepsy with nocturnal wandering and ictal fear. Am J Hum Genet 2006;79:342-350.
-
(2006)
Am J Hum Genet
, vol.79
, pp. 342-350
-
-
Aridon, P.1
Marini, C.2
Di Resta, C.3
-
50
-
-
0028980028
-
A missense mutation in the neuronal nicotinic acetylcholine receptor alpha 4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy
-
Steinlein OK, Mulley JC, Propping P, et al. A missense mutation in the neuronal nicotinic acetylcholine receptor alpha 4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy. Nat Genet 1995;11:201-203.
-
(1995)
Nat Genet
, vol.11
, pp. 201-203
-
-
Steinlein, O.K.1
Mulley, J.C.2
Propping, P.3
-
51
-
-
10744228608
-
A Korean kindred with autosomal dominant nocturnal frontal lobe epilepsy and mental retardation
-
Cho YW, Motamedi GK, Laufenberg I, et al. A Korean kindred with autosomal dominant nocturnal frontal lobe epilepsy and mental retardation. Arch Neurol 2003;60:1625-1632.
-
(2003)
Arch Neurol
, vol.60
, pp. 1625-1632
-
-
Cho, Y.W.1
Motamedi, G.K.2
Laufenberg, I.3
-
52
-
-
0033544326
-
A novel mutation of CHRNA4 responsible for autosomal dominant nocturnal frontal lobe epilepsy
-
Hirose S, Iwata H, Akiyoshi H, et al. A novel mutation of CHRNA4 responsible for autosomal dominant nocturnal frontal lobe epilepsy. Neurology 1999;53:1749-1753.
-
(1999)
Neurology
, vol.53
, pp. 1749-1753
-
-
Hirose, S.1
Iwata, H.2
Akiyoshi, H.3
-
53
-
-
0029900298
-
A beta-subunit mutation in the acetylcholine receptor channel gate causes severe slow-channel syndrome
-
Gomez CM, Maselli R, Gammack J, et al. A beta-subunit mutation in the acetylcholine receptor channel gate causes severe slow-channel syndrome. Ann Neurol 1996;39:712-723.
-
(1996)
Ann Neurol
, vol.39
, pp. 712-723
-
-
Gomez, C.M.1
Maselli, R.2
Gammack, J.3
-
54
-
-
0032722151
-
Mutation causing congenital myasthenia reveals acetylcholine receptor beta/delta subunit interaction essential for assembly
-
Quiram PA, Ohno K, Milone M, et al. Mutation causing congenital myasthenia reveals acetylcholine receptor beta/delta subunit interaction essential for assembly. J Clin Invest 1999;104:1403-1410.
-
(1999)
J Clin Invest
, vol.104
, pp. 1403-1410
-
-
Quiram, P.A.1
Ohno, K.2
Milone, M.3
-
55
-
-
0033763090
-
The nicotinic receptor beta 2 subunit is mutant in nocturnal frontal lobe epilepsy
-
De Fusco M, Becchetti A, Patrignani A, et al. The nicotinic receptor beta 2 subunit is mutant in nocturnal frontal lobe epilepsy. Nat Genet 2000;26:275-276.
-
(2000)
Nat Genet
, vol.26
, pp. 275-276
-
-
De Fusco, M.1
Becchetti, A.2
Patrignani, A.3
-
56
-
-
0035163074
-
CHRNB2 is the second acetylcholine receptor subunit associated with autosomal dominant nocturnal frontal lobe epilepsy
-
Phillips HA, Favre I, Kirkpatrick M, et al. CHRNB2 is the second acetylcholine receptor subunit associated with autosomal dominant nocturnal frontal lobe epilepsy. Am J Hum Genet 2001;68:225-231.
-
(2001)
Am J Hum Genet
, vol.68
, pp. 225-231
-
-
Phillips, H.A.1
Favre, I.2
Kirkpatrick, M.3
-
57
-
-
0034932799
-
Acetylcholine receptor delta subunit mutations underlie a fast-channel myasthenic syndrome and arthrogryposis multiplex congenita
-
Brownlow S, Webster R, Croxen R, et al. Acetylcholine receptor delta subunit mutations underlie a fast-channel myasthenic syndrome and arthrogryposis multiplex congenita. J Clin Invest 2001;108:125-130.
-
(2001)
J Clin Invest
, vol.108
, pp. 125-130
-
-
Brownlow, S.1
Webster, R.2
Croxen, R.3
-
58
-
-
0036135172
-
Novel delta subunit mutation in slowchannel syndrome causes severe weakness by novel mechanisms
-
Gomez CM, Maselli RA, Vohra BP, et al. Novel delta subunit mutation in slowchannel syndrome causes severe weakness by novel mechanisms. Ann Neurol 2002;51:102-112.
-
(2002)
Ann Neurol
, vol.51
, pp. 102-112
-
-
Gomez, C.M.1
Maselli, R.A.2
Vohra, B.P.3
-
59
-
-
8244225989
-
Congenital myasthenic syndromes due to heteroallelic nonsense/missense mutations in the acetylcholine receptor epsilon subunit gene: Identification and functional characterization of six new mutations
-
Ohno K, Quiram PA, Milone M, et al. Congenital myasthenic syndromes due to heteroallelic nonsense/missense mutations in the acetylcholine receptor epsilon subunit gene: identification and functional characterization of six new mutations. Hum Mol Genet 1997;6:753-766.
-
(1997)
Hum Mol Genet
, vol.6
, pp. 753-766
-
-
Ohno, K.1
Quiram, P.A.2
Milone, M.3
-
60
-
-
0033817038
-
Immature end-plates and utrophin deficiency in congenital myasthenic syndrome caused by epsilon-AChR subunit truncating mutations
-
Sieb JP, Kraner S, Rauch M, Steinlein OK. Immature end-plates and utrophin deficiency in congenital myasthenic syndrome caused by epsilon-AChR subunit truncating mutations. Hum Genet 2000;107:160-164.
-
(2000)
Hum Genet
, vol.107
, pp. 160-164
-
-
Sieb, J.P.1
Kraner, S.2
Rauch, M.3
Steinlein, O.K.4
-
61
-
-
23244455514
-
An intronic base alteration of the CHRNE gene leading to a congenital myasthenic syndrome
-
Mller JS, Stucka R, Neudecker S, et al. An intronic base alteration of the CHRNE gene leading to a congenital myasthenic syndrome. Neurology 2005;65:463-465.
-
(2005)
Neurology
, vol.65
, pp. 463-465
-
-
Mller, J.S.1
Stucka, R.2
Neudecker, S.3
-
62
-
-
0032944793
-
Mutation of the acetylcholine receptor epsilon-subunit promoter in congenital myasthenic syndrome
-
Nichols P, Croxen R, Vincent A, et al. Mutation of the acetylcholine receptor epsilon-subunit promoter in congenital myasthenic syndrome. Ann Neurol 1999;45:439-443.
-
(1999)
Ann Neurol
, vol.45
, pp. 439-443
-
-
Nichols, P.1
Croxen, R.2
Vincent, A.3
-
63
-
-
0032589388
-
Novel functional epsilon-subunit polypeptide generated by a single nucleotide deletion in acetylcholine receptor deficiency congenital myasthenic syndrome
-
Croxen R, Newland C, Betty M, Vincent A, Newsom-Davis J, Beeson D. Novel functional epsilon-subunit polypeptide generated by a single nucleotide deletion in acetylcholine receptor deficiency congenital myasthenic syndrome. Ann Neurol 1999;46:639-647.
-
(1999)
Ann Neurol
, vol.46
, pp. 639-647
-
-
Croxen, R.1
Newland, C.2
Betty, M.3
Vincent, A.4
Newsom-Davis, J.5
Beeson, D.6
-
64
-
-
0032589722
-
A common mutation (epsilon1267delG) in congenital myasthenic patients of Gypsy ethnic origin
-
Abicht A, Stucka R, Karcagi V, et al. A common mutation (epsilon1267delG) in congenital myasthenic patients of Gypsy ethnic origin. Neurology 1999;53:1564-1569.
-
(1999)
Neurology
, vol.53
, pp. 1564-1569
-
-
Abicht, A.1
Stucka, R.2
Karcagi, V.3
-
66
-
-
58149392269
-
The CHRNE 1293insG founder mutation is a frequent cause of congenital myasthenia in North Africa
-
Richard P, Gaudon K, Haddad H, et al. The CHRNE 1293insG founder mutation is a frequent cause of congenital myasthenia in North Africa. Neurology 2008;71:1967-1972.
-
(2008)
Neurology
, vol.71
, pp. 1967-1972
-
-
Richard, P.1
Gaudon, K.2
Haddad, H.3
-
67
-
-
0028821376
-
Congenital myasthenic syndrome caused by prolonged acetylcholine receptor channel openings due to a mutation in the M2 domain of the epsilon subunit
-
Ohno K, Hutchinson DO, Milone M, et al. Congenital myasthenic syndrome caused by prolonged acetylcholine receptor channel openings due to a mutation in the M2 domain of the epsilon subunit. Proc Natl Acad Sci USA 1995;92:758-762.
-
(1995)
Proc Natl Acad Sci USA
, vol.92
, pp. 758-762
-
-
Ohno, K.1
Hutchinson, D.O.2
Milone, M.3
-
68
-
-
15844429136
-
Congenital myasthenic syndrome caused by decreased agonist binding affinity due to a mutation in the acetylcholine receptor epsilon subunit
-
Ohno K, Wang HL, Milone M, et al. Congenital myasthenic syndrome caused by decreased agonist binding affinity due to a mutation in the acetylcholine receptor epsilon subunit. Neuron 1996;17:157-170.
-
(1996)
Neuron
, vol.17
, pp. 157-170
-
-
Ohno, K.1
Wang, H.L.2
Milone, M.3
-
69
-
-
0033811495
-
Fundamental gating mechanism of nicotinic receptor channel revealed by mutation causing a congenital myasthenic syndrome
-
Wang HL, Ohno K, Milone M, et al. Fundamental gating mechanism of nicotinic receptor channel revealed by mutation causing a congenital myasthenic syndrome. J Gen Physiol 2000;116:449-462.
-
(2000)
J Gen Physiol
, vol.116
, pp. 449-462
-
-
Wang, H.L.1
Ohno, K.2
Milone, M.3
-
70
-
-
84866117421
-
Highly fatal fastchannel syndrome caused by AChR e subunit mutation at the agonist binding site
-
Shen XM, Brengman JM, Edvardson S, Sine SM, Engel AG. Highly fatal fastchannel syndrome caused by AChR e subunit mutation at the agonist binding site. Neurology 2012;79:449-454.
-
(2012)
Neurology
, vol.79
, pp. 449-454
-
-
Shen, X.M.1
Brengman, J.M.2
Edvardson, S.3
Sine, S.M.4
Engel, A.G.5
-
71
-
-
0029077770
-
A leucine-to-phenylalanine substitution in the acetylcholine receptor ion channel in a family with the slow-channel syndrome
-
Gomez CM, Gammack JT. A leucine-to-phenylalanine substitution in the acetylcholine receptor ion channel in a family with the slow-channel syndrome. Neurology 1995;45:982-985.
-
(1995)
Neurology
, vol.45
, pp. 982-985
-
-
Gomez, C.M.1
Gammack, J.T.2
-
72
-
-
0037188407
-
Myasthenia gravis in a woman with congenital AChR deficiency due to epsilon-subunit mutations
-
Croxen R, Vincent A, Newsom-Davis J, Beeson D. Myasthenia gravis in a woman with congenital AChR deficiency due to epsilon-subunit mutations. Neurology 2002;58:1563-1565.
-
(2002)
Neurology
, vol.58
, pp. 1563-1565
-
-
Croxen, R.1
Vincent, A.2
Newsom-Davis, J.3
Beeson, D.4
-
73
-
-
33746474597
-
Escobar syndrome is a prenatal myasthenia caused by disruption of the acetylcholine receptor fetal gamma subunit
-
Hoffmann K, Muller JS, Stricker S, et al. Escobar syndrome is a prenatal myasthenia caused by disruption of the acetylcholine receptor fetal gamma subunit. Am J Hum Genet 2006;79:303-312.
-
(2006)
Am J Hum Genet
, vol.79
, pp. 303-312
-
-
Hoffmann, K.1
Muller, J.S.2
Stricker, S.3
-
74
-
-
33746474596
-
Mutations in the embryonal subunit of the acetylcholine receptor (CHRNG) cause lethal and Escobar variants of multiple pterygium syndrome
-
Morgan NV, Brueton LA, Cox P, et al. Mutations in the embryonal subunit of the acetylcholine receptor (CHRNG) cause lethal and Escobar variants of multiple pterygium syndrome. Am J Hum Genet 2006;79:390-395.
-
(2006)
Am J Hum Genet
, vol.79
, pp. 390-395
-
-
Morgan, N.V.1
Brueton, L.A.2
Cox, P.3
|